CDSCO declared a list of Drugs, Medical Devices, and Cosmetics, as Not of Standard Quality/Spurious/Adulterated/Misbranded for March 2023

Apr 27, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Central Drugs Standard Control Organisation (CDSCO) on April 24, 2023, issued a list of Drugs, Medical Devices, and Cosmetics, declaring them as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of March 2023.

The Table with the Name of Drugs/medical devices/cosmetics, Batch No./Date of Manufacture/Date of Expiry/Manufacture, Reason for failure, Drawn by, and From have been inserted

A few Drugs/medical devices/cosmetics are as follows: -

1. Telmirid-40 (Telmisartan Tablets I.P. 40 mg)

2. Domperidone Tablets I.P. 10 mg

3. DACILON 0.5 (Dactinomycin for Injection USP 0.5 mg)

4. (DUCOLAX) Bisacodyl Tablet I.P. 5 mg

5. Meswak (Toothpaste for complete Tooth and Gum Care)

6. Vitamin B Complex Tablets

7. Vitamin C Injection IP and Vitamin B12, Folic Acid and Niacinamide Injection (Eldervit-12)

8. Ascorbic Acid Tablets IP 500mg

 

 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT